GemVax Acquires 2.55 Million Shares of Samsung Pharmaceutical for 10 Billion Won
[Asia Economy Reporter Kim Hyo-jin] GemVax announced on the 21st that it will additionally acquire 2,555,583 shares of its affiliate Samsung Pharmaceutical, a company engaged in pharmaceutical manufacturing and sales, for approximately 10 billion KRW.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- [Breaking] Bloomberg: "Korean HMM Oil Tanker Attempts Escape from Strait of Hormuz"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
After acquiring the shares, GemVax's stake in Samsung Pharmaceutical will be 11.4%. The scheduled date for the share acquisition is the 2nd of next month.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
